Trial Outcomes & Findings for Investigating Healthcare Disparities in Vitiligo (NCT NCT06097494)

NCT ID: NCT06097494

Last Updated: 2025-03-17

Results Overview

Adjusted odds ratio calculated using logistic regression.

Recruitment status

COMPLETED

Target enrollment

39374 participants

Primary outcome timeframe

2 years

Results posted on

2025-03-17

Participant Flow

All adults and children (aged ≥ 13 years) contributing to the Optimum Patient Care Research Database (OPCRD) between 1 January 2004 and 31 December 2020, without a diagnosis of vitiligo prior to1 January 2004 were eligible for inclusion.

Participants with a diagnosis for an alternative depigmenting disorder or were diagnosed with vitiligo within 6 months of registering with their general practice (GP) were excluded.

Participant milestones

Participant milestones
Measure
People With Vitiligo
Children and adults with new onset Vitiligo registered with OPCRD during the study period. No intervention: Observational analysis of usual care only.
People Without Vitiligo (Reference Group)
Children and adults without Vitiligo registered with OPCRD during the study period No intervention: Observational analysis of usual care only.
Overall Study
STARTED
7890
31484
Overall Study
COMPLETED
7890
31484
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Investigating Healthcare Disparities in Vitiligo

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
People With Vitiligo
n=7890 Participants
Children (≥ 13 years) and adults with new onset Vitiligo registered with Optimum Patient Care Research Database during the study period. No intervention: Observational analysis of usual care only.
People Without Vitiligo
n=31484 Participants
Children (≥ 13 years) and adults without Vitiligo registered with Optimum Patient Care Research Database during the study period No intervention: Observational analysis of usual care only.
Total
n=39374 Participants
Total of all reporting groups
Age, Continuous
43 years
n=5 Participants
42 years
n=7 Participants
42.5 years
n=5 Participants
Age, Customized
13-17 years
487 Participants
n=5 Participants
1915 Participants
n=7 Participants
2402 Participants
n=5 Participants
Age, Customized
18-29 years
1370 Participants
n=5 Participants
5471 Participants
n=7 Participants
6841 Participants
n=5 Participants
Age, Customized
30-49 years
3063 Participants
n=5 Participants
12242 Participants
n=7 Participants
15305 Participants
n=5 Participants
Age, Customized
50+ years
2970 Participants
n=5 Participants
11856 Participants
n=7 Participants
14826 Participants
n=5 Participants
Sex: Female, Male
Female
4131 Participants
n=5 Participants
16492 Participants
n=7 Participants
20623 Participants
n=5 Participants
Sex: Female, Male
Male
3759 Participants
n=5 Participants
14992 Participants
n=7 Participants
18751 Participants
n=5 Participants
Race/Ethnicity, Customized
White
3726 Participants
n=5 Participants
14894 Participants
n=7 Participants
18620 Participants
n=5 Participants
Race/Ethnicity, Customized
Black
196 Participants
n=5 Participants
708 Participants
n=7 Participants
904 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
1197 Participants
n=5 Participants
4775 Participants
n=7 Participants
5972 Participants
n=5 Participants
Race/Ethnicity, Customized
Mixed
80 Participants
n=5 Participants
332 Participants
n=7 Participants
412 Participants
n=5 Participants
Race/Ethnicity, Customized
Other
299 Participants
n=5 Participants
1220 Participants
n=7 Participants
1519 Participants
n=5 Participants
Race/Ethnicity, Customized
Not recorded
2392 Participants
n=5 Participants
9555 Participants
n=7 Participants
11947 Participants
n=5 Participants
Index of Multiple Deprivation
1 (most deprived)
1525 Participants
n=5 Participants
6094 Participants
n=7 Participants
7619 Participants
n=5 Participants
Index of Multiple Deprivation
2
1392 Participants
n=5 Participants
5545 Participants
n=7 Participants
6937 Participants
n=5 Participants
Index of Multiple Deprivation
3
1355 Participants
n=5 Participants
5418 Participants
n=7 Participants
6773 Participants
n=5 Participants
Index of Multiple Deprivation
4
1527 Participants
n=5 Participants
6084 Participants
n=7 Participants
7611 Participants
n=5 Participants
Index of Multiple Deprivation
5 (least deprived)
1484 Participants
n=5 Participants
5928 Participants
n=7 Participants
7412 Participants
n=5 Participants
Index of Multiple Deprivation
Not recorded
607 Participants
n=5 Participants
2415 Participants
n=7 Participants
3022 Participants
n=5 Participants
Body Mass Index, Categorical
< 18.5 (underweight)
269 Participants
n=5 Participants
1054 Participants
n=7 Participants
1323 Participants
n=5 Participants
Body Mass Index, Categorical
18.5-25 (normal weight)
2324 Participants
n=5 Participants
8504 Participants
n=7 Participants
10828 Participants
n=5 Participants
Body Mass Index, Categorical
25-30 (overweight)
2386 Participants
n=5 Participants
8938 Participants
n=7 Participants
11324 Participants
n=5 Participants
Body Mass Index, Categorical
30-35 (class I obesity)
1137 Participants
n=5 Participants
4410 Participants
n=7 Participants
5547 Participants
n=5 Participants
Body Mass Index, Categorical
35-40 (class II obesity)
372 Participants
n=5 Participants
1654 Participants
n=7 Participants
2026 Participants
n=5 Participants
Body Mass Index, Categorical
> 40 (class III obesity)
214 Participants
n=5 Participants
940 Participants
n=7 Participants
1154 Participants
n=5 Participants
Body Mass Index, Categorical
Not recorded
1188 Participants
n=5 Participants
5984 Participants
n=7 Participants
7172 Participants
n=5 Participants
Smoking status, Categorical
Never smoked
2709 Participants
n=5 Participants
10000 Participants
n=7 Participants
12709 Participants
n=5 Participants
Smoking status, Categorical
Current smoker
1229 Participants
n=5 Participants
6114 Participants
n=7 Participants
7343 Participants
n=5 Participants
Smoking status, Categorical
Ex-smoker
3642 Participants
n=5 Participants
13435 Participants
n=7 Participants
17077 Participants
n=5 Participants
Smoking status, Categorical
Not recorded
310 Participants
n=5 Participants
1935 Participants
n=7 Participants
2245 Participants
n=5 Participants
Alcohol consumption, Categorical
None
2605 Participants
n=5 Participants
10014 Participants
n=7 Participants
12619 Participants
n=5 Participants
Alcohol consumption, Categorical
Within limits
2913 Participants
n=5 Participants
11376 Participants
n=7 Participants
14289 Participants
n=5 Participants
Alcohol consumption, Categorical
In excess of limits
1005 Participants
n=5 Participants
3685 Participants
n=7 Participants
4690 Participants
n=5 Participants
Alcohol consumption, Categorical
Harmful
121 Participants
n=5 Participants
463 Participants
n=7 Participants
584 Participants
n=5 Participants
Alcohol consumption, Categorical
Not recorded
1246 Participants
n=5 Participants
5946 Participants
n=7 Participants
7192 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 2 years

Adjusted odds ratio calculated using logistic regression.

Outcome measures

Outcome measures
Measure
People With Vitiligo
n=7890 Participants
Children (≥ 13 years) and adults with new onset Vitiligo No intervention: Observational analysis of usual care only.
People Without Vitiligo
n=31484 Participants
Children (≥ 13 years) and adults without Vitiligo (reference group) No intervention: Observational analysis of usual care only.
Risk of Depression Within Patients With Vitiligo
1412 Events
5395 Events

PRIMARY outcome

Timeframe: 2 years

Adjusted odds ratio calculated using logistic regression.

Outcome measures

Outcome measures
Measure
People With Vitiligo
n=7890 Participants
Children (≥ 13 years) and adults with new onset Vitiligo No intervention: Observational analysis of usual care only.
People Without Vitiligo
n=31484 Participants
Children (≥ 13 years) and adults without Vitiligo (reference group) No intervention: Observational analysis of usual care only.
Risk of Anxiety Within Patients With Vitiligo
708 Events
2430 Events

PRIMARY outcome

Timeframe: 2 years

Adjusted odds ratio of depression or anxiety in people with vitiligo calculated using logistic regression .

Outcome measures

Outcome measures
Measure
People With Vitiligo
n=7890 Participants
Children (≥ 13 years) and adults with new onset Vitiligo No intervention: Observational analysis of usual care only.
People Without Vitiligo
n=31484 Participants
Children (≥ 13 years) and adults without Vitiligo (reference group) No intervention: Observational analysis of usual care only.
Risk of Depression or Anxiety Within Patients With Vitiligo
1614 Events
6064 Events

SECONDARY outcome

Timeframe: 2 years

Describe any disparities in primary care usage (primary care visits) reported as adjusted incidence rate ratios

Outcome measures

Outcome measures
Measure
People With Vitiligo
n=7890 Participants
Children (≥ 13 years) and adults with new onset Vitiligo No intervention: Observational analysis of usual care only.
People Without Vitiligo
n=31484 Participants
Children (≥ 13 years) and adults without Vitiligo (reference group) No intervention: Observational analysis of usual care only.
Primary Care Encounters
134207 Events
439633 Events

SECONDARY outcome

Timeframe: 2 years

Population: Dermatology referrals were assessed only in patients with vitiligo

Percentage of participants diagnosed with vitligo and having a recorded dermatology referral event wthin two year estimated using using the Kaplan-Meier method.

Outcome measures

Outcome measures
Measure
People With Vitiligo
n=7890 Participants
Children (≥ 13 years) and adults with new onset Vitiligo No intervention: Observational analysis of usual care only.
People Without Vitiligo
Children (≥ 13 years) and adults without Vitiligo (reference group) No intervention: Observational analysis of usual care only.
Dermatology Referrals
20 percentage of participants analyzed
Interval 19.0 to 21.0

SECONDARY outcome

Timeframe: 2 years

Describe any disparities in healthcare utilisation ( mental health referrals) reported as adjusted hazard ratios

Outcome measures

Outcome measures
Measure
People With Vitiligo
n=7890 Participants
Children (≥ 13 years) and adults with new onset Vitiligo No intervention: Observational analysis of usual care only.
People Without Vitiligo
n=31484 Participants
Children (≥ 13 years) and adults without Vitiligo (reference group) No intervention: Observational analysis of usual care only.
Mental Health Referrals
311 Events
1191 Events

SECONDARY outcome

Timeframe: 2 years

Population: Subset of participants of working age

Describe any disparities in work-related impact (unemployment) reported as adjusted hazard ratios.

Outcome measures

Outcome measures
Measure
People With Vitiligo
n=6241 Participants
Children (≥ 13 years) and adults with new onset Vitiligo No intervention: Observational analysis of usual care only.
People Without Vitiligo
n=23187 Participants
Children (≥ 13 years) and adults without Vitiligo (reference group) No intervention: Observational analysis of usual care only.
Unemployment
111 Events
436 Events

SECONDARY outcome

Timeframe: 2 years

Population: Subset of participants of working age

Describe any disparities in work-related impact (time off work) reported as adjusted hazard ratios.

Outcome measures

Outcome measures
Measure
People With Vitiligo
n=6241 Participants
Children (≥ 13 years) and adults with new onset Vitiligo No intervention: Observational analysis of usual care only.
People Without Vitiligo
n=23187 Participants
Children (≥ 13 years) and adults without Vitiligo (reference group) No intervention: Observational analysis of usual care only.
Time Off Work
746 Events
2472 Events

SECONDARY outcome

Timeframe: 2 years

Describe any disparities in sleep disturbance reported as adjusted hazard ratios.

Outcome measures

Outcome measures
Measure
People With Vitiligo
n=7890 Participants
Children (≥ 13 years) and adults with new onset Vitiligo No intervention: Observational analysis of usual care only.
People Without Vitiligo
n=31484 Participants
Children (≥ 13 years) and adults without Vitiligo (reference group) No intervention: Observational analysis of usual care only.
Sleep Disturbance
318 Events
1102 Events

Adverse Events

People With Vitiligo

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

People Without Vitiligo

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Ranjit Nagra

Pfizer Ltd

Phone: 01304 616161

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place